Trevi Therapeutics, Inc. (TRVI)

NASDAQ: TRVI · Real-Time Price · USD

6.35

-0.11 (-1.63%)

May 14, 2025, 3:05 PM - Market open

Trevi Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2019
Period Ending	May '25 May 14, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2019
Market Capitalization	646	368	86	116	20	44	Upgrade
Market Cap Growth	155.61%	330.28%	-26.01%	472.04%	-54.55%	-33.49%	Upgrade
Enterprise Value	553	304	-2	1	6	5	Upgrade
Last Close Price	6.46	4.12	1.34	1.93	0.78	2.42	Upgrade
PB Ratio	6.48	3.70	1.04	1.08	1.18	1.63	Upgrade
P/TBV Ratio	6.59	3.70	1.04	1.08	1.18	1.63	Upgrade
Debt / Equity Ratio	0.01	0.01	0.02	0.09	0.86	0.52	Upgrade
Quick Ratio	15.11	10.29	14.33	8.99	2.90	8.10	Upgrade
Current Ratio	15.38	10.41	15.03	9.15	2.98	8.33	Upgrade
Return on Equity (ROE)	-55.12%	-52.59%	-30.59%	-46.82%	-153.03%	-80.07%	Upgrade
Return on Assets (ROA)	-34.41%	-32.15%	-19.96%	-23.15%	-47.42%	-37.91%	Upgrade
Return on Capital (ROIC)	-36.70%	-34.90%	-21.15%	-25.18%	-55.37%	-42.13%	Upgrade
Earnings Yield	-7.23%	-13.01%	-33.97%	-25.21%	-167.88%	-73.64%	Upgrade
FCF Yield	-6.30%	-10.40%	-37.22%	-24.50%	-143.18%	-65.27%	Upgrade
Buyback Yield / Dilution	-7.29%	-2.97%	-53.44%	-182.56%	-26.48%	-53.88%	Upgrade

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q